Anzor’s FGF-based peptide and small molecule drugs target  fibroblast growth factor receptors (FGFRs), which are involved in various biological processes including cell proliferation, survival, migration, and differentiation. These drugs can act as either agonists or antagonists of FGFRs, depending on the therapeutic goals.